The new complex [PtMe2(BPMA)], 1,
BPMA = bis(2-pyridylmethyl)amine, is shown to
contain bidentate BPMA with one of the pyridyl groups not coordinated
to platinum.
Complex 1 reacts with HX (X = Cl, BF4) at
room temperature to yield
[PtHMe2(BPMA)][X],
which may exist in two isomeric forms, each containing tridentate BPMA.
The major initial
product 2 has the hydride trans to a pyridyl
group, but this equilibrates with isomer 3 in
which the hydride is trans to an amine. The cationic
methyl(hydrido)platinum(IV) complexes
2 and 3 are stable at room temperature for
several hours, but undergo slow reductive
elimination of CH4 to yield [PtMe(BPMA)][X],
4. Complex 1 reacts with DCl to give
[PtDMe2(BPMA)][X], and deuterium incorporation at the methyl group
trans to amine occurs slowly;
the methane formed by subsequent reductive elimination is a mixture of
CH4, CH3D, and
CH2D2. Reaction of 1 with MeI
initially yields a mixture of two compounds,
[PtMe3(BPMA)][I], 5a, and a neutral compound,
[PtIMe3(BPMA)], 6, but 6
isomerizes to 5 over a
period of 2 h at room temperature. Reaction of 1 with
CD3I gives
[PtMe2(CD3)(BPMA)][I],
5a
*, and
[PtIMe2(CD3)(BPMA)],
6
*, with CD3 largely trans
to pyridyl or iodide, respectively,
but equilibration gives a mixture of 5a
* and
5a
**, in which CD3 is
trans to amine. In contrast
to the reaction with MeI, oxidative addition of
CF3SO3Me to 1 gives only
[PtMe3(BPMA)][CF3SO3], 5b. Reaction of
1 with allyl bromide yields a mixture of two products,
[PtMe2(CH2CHCH2)(BPMA)][Br], 7, and
[PtBrMe2(CH2CHCH2)(BPMA)],
8; complex 8 isomerizes
rapidly to 7. Complexes 4 and 7
have been characterized by X-ray structure determinations
and are shown to contain the BPMA ligands in fac and
mer coordination modes.